Skip to main content
. Author manuscript; available in PMC: 2015 Oct 28.
Published in final edited form as: Clin Genitourin Cancer. 2013 Nov 14;12(4):241–250. doi: 10.1016/j.clgc.2013.11.020

Figure 3.

Figure 3

Mean Plasma Concentration vs. Time for Vatalanib and Everolimus. (A) Pharmacokinetic (PK) Sampling for Vatalanib Performed on Cycle 1 day 14 and Cycle 1 day 29. (B) PK Sampling for Everolimus Performed on Cycle 1 day 29 With Peak Concentrations at 2 Hours